Laboratory Medicine and Quality Assurance

Table. 3.

Test items and instruments that showed <80% acceptable rates

Specimen 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08 21-09 21-10 21-11 21-12
pH E Si R, Sy, Si E R, Sy, Si R, Si
Protein Ab, D, E, B Ab, D Ab, D
Glucose Si
Ketone
Bilirubin E Si Si, B Si, Ak Si, B Si, A, B Si, B Si, A, B
Blood B
Urobilinogen Y, Sy, Si, Ak Y, Sy, Si, Ak Y, Sy, Si, Ak, B Si, Ak Y, Sy, Si, Ak Y, Sy, Si, Ak Y, Sy, Si, Ak, B Si, Ak Y, Sy, Si, Ak Y, Sy, Si, Ak Y, Sy, Si, Ak, B R, Si, Ak
Nitrite
Leukocyte

The instruments used were as follows: YD (YD Diagnostics, Yongin, Korea), Abbott (Abbott Laboratories, Abbott Park, IL, USA), Roche (Roche Diagnostics, Mannheim, Germany), DFI (DFI Co. Ltd., Gimhae, Korea), Symex (Symex Co., Kobe, Japan), Siemens (Siemens Healthcare, Erlangen, Germany), Eiken (Eiken Chemical Co., Tokyo, Japan), Arkray (Arkray Inc., Kyoto, Japan), and Beckman (Beckman Coulter Inc., Brea, CA, USA).

Abbreviations: Ab, Abbott; Ak, Arkray; B, Beckman; D, DFI; E, Eiken; R, Roche; Si, Siemens; Sy, Sysmex; Y, YD.

Lab Med Qual Assur 2023;45:1~9 https://doi.org/10.15263/jlmqa.2023.45.1.1
© Lab Med Qual Assur